使用Sensititre YeastOne比色法抗真菌鉴定板与NCCLS M27 - A2参考方法对新型抗真菌药物针对念珠菌属临床分离株进行多中心比较。
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
作者信息
Espinel-Ingroff A, Pfaller M, Messer S A, Knapp C C, Holliday N, Killian S B
机构信息
VCU Medical Center, Richmond, Virginia 23298-0049, USA.
出版信息
J Clin Microbiol. 2004 Feb;42(2):718-21. doi: 10.1128/JCM.42.2.718-721.2004.
Abstract
A multicenter (three centers) study compared MICs obtained by the Sensititre YeastOne Colorimetric Antifungal plate to reference microdilution broth (NCCLS M27-A2 document) MICs of three new triazoles (posaconazole, ravuconazole, and voriconazole) and the echinocandin caspofungin acetate for 100 isolates of Candida spp. In addition, amphotericin B and fluconazole were tested as control drugs. Colorimetric MICs of caspofungin and amphotericin B corresponded to the first blue well (no growth), and MICs of the other agents corresponded to the first slightly purple or blue well. Two comparisons of MIC pairs by the two methods were evaluated: 24-h colorimetric MICs were compared to NCCLS MICs at 24 and at 48 h. The interlaboratory reproducibility of YeastOne and reference MICs was also examined. The best performance of the YeastOne plate was with 24-h MICs (overall, 95 to 99% agreement) for all the species and antifungal agents. These results suggest the potential value of the YeastOne plate for use in the clinical laboratory for the four new antifungal agents evaluated.
摘要
一项多中心（三个中心）研究比较了使用Sensititre YeastOne比色抗真菌药敏板获得的最小抑菌浓度（MIC）与参考微量稀释肉汤法（NCCLS M27 - A2文件）测定的三种新型三唑类药物（泊沙康唑、雷夫康唑和伏立康唑）以及棘白菌素类药物醋酸卡泊芬净对100株念珠菌属菌株的MIC。此外，两性霉素B和氟康唑作为对照药物进行了测试。卡泊芬净和两性霉素B的比色MIC对应于第一个蓝色孔（无生长），其他药物的MIC对应于第一个略呈紫色或蓝色的孔。评估了两种方法对MIC值对的两种比较：将24小时比色MIC与24小时和48小时的NCCLS MIC进行比较。还检查了YeastOne和参考MIC在不同实验室间的可重复性。YeastOne药敏板在所有菌种和抗真菌药物的24小时MIC测定中表现最佳（总体一致性为95%至99%）。这些结果表明YeastOne药敏板在临床实验室用于评估这四种新型抗真菌药物具有潜在价值。
相似文献
1
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.使用Sensititre YeastOne比色法抗真菌鉴定板与NCCLS M27 - A2参考方法对新型抗真菌药物针对念珠菌属临床分离株进行多中心比较。
J Clin Microbiol. 2004 Feb;42(2):718-21. doi: 10.1128/JCM.42.2.718-721.2004.
2
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.Sensititre YeastOne比色法抗真菌药敏板与美国国家临床实验室标准委员会M27-A参考方法对常见和新出现的念珠菌属、隐球菌属以及其他酵母菌和酵母样生物体临床分离株检测的多中心比较。
J Clin Microbiol. 1999 Mar;37(3):591-5. doi: 10.1128/JCM.37.3.591-595.1999.
3
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.用于新型三唑类药物伏立康唑、泊沙康唑和雷夫康唑抗真菌药敏试验的 Sensititre YeastOne 比色法抗真菌药敏板的临床评估
J Clin Microbiol. 2004 Oct;42(10):4577-80. doi: 10.1128/JCM.42.10.4577-4580.2004.
4
Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.用于念珠菌属抗真菌药敏试验的Sensititre YeastOne比色微量稀释板与NCCLS肉汤微量稀释法的比较。
Chemotherapy. 2002 Mar;48(1):21-5. doi: 10.1159/000048583.
5
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.用于棘白菌素类药物阿尼芬净、卡泊芬净和米卡芬净抗真菌药敏试验的 Sensititre YeastOne 比色法抗真菌药敏板的临床评估。
J Clin Microbiol. 2008 Jul;46(7):2155-9. doi: 10.1128/JCM.00493-08. Epub 2008 May 7.
6
Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.念珠菌临床分离株的Sensititre YeastOne卡泊芬净药敏试验：与NCCLS M27-A2多中心研究结果的相关性。
Antimicrob Agents Chemother. 2005 Apr;49(4):1604-7. doi: 10.1128/AAC.49.4.1604-1607.2005.
7
Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.比较 Sensititre YeastOne 比色法抗真菌药敏检测板与 CLSI 微量稀释法对抗真菌药物对念珠菌属的药敏试验，采用新的临床折点和流行病学切点值。
Diagn Microbiol Infect Dis. 2012 Aug;73(4):365-8. doi: 10.1016/j.diagmicrobio.2012.05.008. Epub 2012 Jun 20.
8
Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.采用临床和实验室标准协会M27 - A2参考肉汤微量稀释法，对Etest和sensititre酵母样菌药敏板检测念珠菌对七种抗真菌药物敏感性进行比较评估。
J Clin Microbiol. 2007 Mar;45(3):698-706. doi: 10.1128/JCM.01840-06. Epub 2007 Jan 3.
9
Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method.1994年至1998年瑞典念珠菌属血流分离株的抗真菌药敏趋势：E-test和Sensititre YeastOne比色抗真菌药敏板与NCCLS M27-A参考方法的比较
J Clin Microbiol. 2001 Nov;39(11):4181-3. doi: 10.1128/JCM.39.11.4181-4183.2001.
10
Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel.使用 CLSI 参考肉汤微量稀释法和 Sensititre YeastOne 比色板对牛乳腺炎分离株 Prototheca bovis 进行药敏试验。
Med Mycol. 2021 Dec 3;59(12):1257-1261. doi: 10.1093/mmy/myab063.
引用本文的文献
1
Antifungal Susceptibility Testing: A Primer for Clinicians.抗真菌药敏试验：临床医生入门指南。
Open Forum Infect Dis. 2021 Sep 9;8(11):ofab444. doi: 10.1093/ofid/ofab444. eCollection 2021 Nov.
2
Continual Decline in Azole Susceptibility Rates in Over a 9-Year Period in China.中国9年期间唑类药物敏感性率持续下降。
Front Microbiol. 2021 Jul 9;12:702839. doi: 10.3389/fmicb.2021.702839. eCollection 2021.
3
Direct Fluconazole Disk Susceptibility Testing for Candida glabrata-Positive Blood Cultures.直接氟康唑药敏纸片法检测阳性血培养的光滑念珠菌。
J Clin Microbiol. 2021 Jun 18;59(7):e0031121. doi: 10.1128/JCM.00311-21.
4
Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Species.四种常见菌种中使用不同解释标准检测获得性唑类和棘白菌素类耐药分子机制的两种商业肉汤微量稀释法的评估。
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.00740-20.
5
Antifungal Susceptibility Testing: Current Approaches.抗真菌药物敏感性测试：当前方法。
Clin Microbiol Rev. 2020 Apr 29;33(3). doi: 10.1128/CMR.00069-19. Print 2020 Jun 17.
6
Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital.血流感染：沙特一家三级医疗医院10年间发生模式及抗真菌药敏性的变化
Can J Infect Dis Med Microbiol. 2019 Dec 17;2019:2015692. doi: 10.1155/2019/2015692. eCollection 2019.
7
Epidemiology And Antifungal Susceptibility Patterns Of Invasive Fungal Infections From 2012 To 2014 In A Teaching Hospital In Central China.2012年至2014年中国中部某教学医院侵袭性真菌感染的流行病学及抗真菌药敏模式
Infect Drug Resist. 2019 Nov 22;12:3641-3651. doi: 10.2147/IDR.S227839. eCollection 2019.
8
Environmentally-Friendly Green Approach for the Production of Zinc Oxide Nanoparticles and Their Anti-Fungal, Ovicidal, and Larvicidal Properties.用于生产氧化锌纳米颗粒的环保绿色方法及其抗真菌、杀卵和杀幼虫特性。
Nanomaterials (Basel). 2018 Jul 6;8(7):500. doi: 10.3390/nano8070500.
9
Vegetable Peel Waste for the Production of ZnO Nanoparticles and its Toxicological Efficiency, Antifungal, Hemolytic, and Antibacterial Activities.用于生产氧化锌纳米颗粒的蔬菜皮废料及其毒理学效率、抗真菌、溶血和抗菌活性。
Nanoscale Res Lett. 2016 Dec;11(1):546. doi: 10.1186/s11671-016-1750-9. Epub 2016 Dec 8.
10
Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.采用新的商业比色微量稀释法（SensiQuattro Candida EU）与MIC试纸条法及欧洲抗菌药物敏感性试验委员会（EUCAST）肉汤微量稀释法对侵袭性念珠菌分离株进行药敏试验的比较评估。
J Clin Microbiol. 2015 Jan;53(1):255-61. doi: 10.1128/JCM.02830-14. Epub 2014 Nov 12.
本文引用的文献
1
Comparison of caspofungin and amphotericin B for invasive candidiasis.卡泊芬净与两性霉素B治疗侵袭性念珠菌病的比较。
N Engl J Med. 2002 Dec 19;347(25):2020-9. doi: 10.1056/NEJMoa021585.
2
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.雷夫康唑和伏立康唑与四种已获批的全身性抗真菌药物对6970株念珠菌属临床分离株的体外活性比较
Antimicrob Agents Chemother. 2002 Jun;46(6):1723-7. doi: 10.1128/AAC.46.6.1723-1727.2002.
3
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.1997年至2000年从患有血流感染的儿科和成人患者中分离出的念珠菌属的抗真菌药敏趋势：SENTRY抗菌监测计划
J Clin Microbiol. 2002 Mar;40(3):852-6. doi: 10.1128/JCM.40.3.852-856.2002.
4
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.采用美国国家临床实验室标准化委员会（NCCLS）方法测定伏立康唑及对照药物的体外抗真菌活性：文献综述
Mycopathologia. 2001;150(3):101-15. doi: 10.1023/a:1010954803886.
5
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.十种抗真菌药物肉汤微量稀释药敏试验的质量控制限度
J Clin Microbiol. 2000 Sep;38(9):3457-9. doi: 10.1128/JCM.38.9.3457-3459.2000.
6
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.Sensititre YeastOne比色法抗真菌药敏板与美国国家临床实验室标准委员会M27-A参考方法对常见和新出现的念珠菌属、隐球菌属以及其他酵母菌和酵母样生物体临床分离株检测的多中心比较。
J Clin Microbiol. 1999 Mar;37(3):591-5. doi: 10.1128/JCM.37.3.591-595.1999.
7
Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel.Sensititre YeastOne比色法抗真菌药敏板检测MIC结果的多中心可重复性
Diagn Microbiol Infect Dis. 1998 Aug;31(4):543-7. doi: 10.1016/s0732-8893(98)00026-1.
8
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.新型三唑类药物SCH56592与棘白菌素类药物MK-0991（L-743,872）和LY303366对机会性丝状真菌、双相真菌和酵母的体外活性比较。
J Clin Microbiol. 1998 Oct;36(10):2950-6. doi: 10.1128/JCM.36.10.2950-2956.1998.
9
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.新型三唑类药物伏立康唑（UK-109,496）对机会性丝状真菌和双相真菌以及常见和新出现的酵母病原体的体外活性。
J Clin Microbiol. 1998 Jan;36(1):198-202. doi: 10.1128/JCM.36.1.198-202.1998.
10
Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose.使用酪蛋白胨琼脂和含2%葡萄糖的凝固型RPMI 1640培养基，对Etest法检测致病性酵母对五种抗真菌药物的抗真菌药敏性进行实验室间评估。
J Clin Microbiol. 1996 Apr;34(4):848-52. doi: 10.1128/jcm.34.4.848-852.1996.
Zotero 插件